Rosewich Hendrik, Sweney Matthew T, DeBrosse Suzanne, Ess Kevin, Ozelius Laurie, Andermann Eva, Andermann Frederick, Andrasco Gene, Belgrade Alice, Brashear Allison, Ciccodicola Sharon, Egan Lynn, George Alfred L, Lewelt Aga, Magelby Joshua, Merida Mario, Newcomb Tara, Platt Vicky, Poncelin Dominic, Reyna Sandra, Sasaki Masayuki, Sotero de Menezes Marcio, Sweadner Kathleen, Viollet Louis, Zupanc Mary, Silver Kenneth, Swoboda Kathryn
Department of Pediatrics and Pediatric Neurology (H.R.), Georg August University, Göttingen, Germany; Division of Clinical Genetics (L.V.), Department of Pediatrics (T.N., M.T.S.) and Department of Neurology (M.T.S.), University of Utah, Salt Lake City; Center for Human Genetics (S.D.), University Hospitals and Case Western Reserve University, Cleveland, OH; Division of Pediatric Neurology (K.E.), Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN; Center for Human Genetics Research (L.O., M.M., K. Swoboda), Department of Neurology, Massachusetts General Hospital, Boston; Neurogenetics Unit (E.A.) and Epilepsy Research Group (E.A., F.A.), Montreal Neurological Hospital and Institute; Department of Neurology and Neurosurgery (E.A., F.A.), Department of Human Genetics (E.A.), and Department of Pediatrics (F.A.), McGill University, Quebec, Canada; Alternating Hemiplegia of Childhood Foundation (G.A., S.C., L.E., V.P.), Southfield, MI; BCBA (A. Belgrade), Belgrade Behavior Consulting, Chicago, IL; Department of Neurology (A. Brashear), Wake Forest School of Medicine, Winston-Salem, NC; Department of Pharmacology (A.L.G.), Northwestern University Feinberg School of Medicine, Chicago, IL; Department of Pediatrics (A.L.), University of Florida College of Medicine, Jacksonville; Integrative Neuropsychology (J.M.), Fairlawn, OH; Association Française de l'Hémiplégie Alternante (D.P.), Paris, France; Rare Disease Innovation Unit (S.R.), Clinical Development Program, Biogen, Cambridge, MA; Department of Child Neurology (M.S.), National Center of Neurology and Psychiatry, Kodaira, Japan; Swedish Neuroscience Institute (M.S.d.M.), Swedish Medical Center, Seattle, WA; Department of Neurosurgery (K. Sweadner), Massachusetts General Hospital and Harvard Medical School, Boston; Neuroscience Institute (M.Z.), Children's Hospital of Orange County, CA; and Departments of Pediatrics and Neurology (K. Silver), University of Chicago and Comer Children's Hospital, Chicago, IL.
Neurol Genet. 2017 Mar 2;3(2):e139. doi: 10.1212/NXG.0000000000000139. eCollection 2017 Apr.
-related neurologic disorders encompass a broad range of phenotypes that extend well beyond initial phenotypic criteria associated with alternating hemiplegia of childhood (AHC) and rapid-onset dystonia parkinsonism.
In 2014, the Alternating Hemiplegia of Childhood Foundation hosted a multidisciplinary workshop intended to address fundamental challenges surrounding the diagnosis and management of individuals with -related disorders.
Workshop attendees were charged with the following: (1) to achieve consensus on expanded diagnostic criteria to facilitate the identification of additional patients, intended to supplement existing syndrome-specific diagnostic paradigms; (2) to standardize definitions for the broad range of paroxysmal manifestations associated with AHC to disseminate to families; (3) to create clinical recommendations for common recurrent issues facing families and medical care providers; (4) to review data related to the death of individuals in the Alternating Hemiplegia of Childhood Foundation database to guide future efforts in identifying at-risk subjects and potential preventative measures; and (5) to identify critical gaps where we most need to focus national and international research efforts.
This report summarizes recommendations of the workshop committee, highlighting the key phenotypic features to facilitate the diagnosis of possible mutations, providing recommendations for genetic testing, and outlining initial acute management for common recurrent clinical conditions, including epilepsy.
与[疾病名称]相关的神经系统疾病涵盖了广泛的表型,远远超出了与儿童交替性偏瘫(AHC)和快速发作性肌张力障碍帕金森综合征相关的初始表型标准。
2014年,儿童交替性偏瘫基金会举办了一次多学科研讨会,旨在解决围绕与[疾病名称]相关疾病患者的诊断和管理的基本挑战。
研讨会参与者负责以下事项:(1)就扩展的诊断标准达成共识,以促进更多患者的识别,旨在补充现有的特定综合征诊断模式;(2)规范与AHC相关的广泛阵发性表现的定义,以便传达给家庭;(3)为家庭和医疗服务提供者面临的常见复发问题制定临床建议;(4)审查儿童交替性偏瘫基金会数据库中与个体死亡相关的数据,以指导未来识别高危受试者和潜在预防措施的工作;(5)确定我们最需要集中国家和国际研究工作的关键差距。
本报告总结了研讨会委员会的建议,强调了有助于诊断可能的[基因突变名称]突变的关键表型特征,提供了基因检测建议,并概述了常见复发临床病症(包括癫痫)的初始急性处理方法。